Open AccessEffects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients
Author(s) -
Kim Min Kyung,
Kim DooMan
Publication year - 2021
Publication title -
journal of diabetes investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.089
H-Index - 50
eISSN - 2040-1124
pISSN - 2040-1116
DOI - 10.1111/jdi.13552
Subject(s) - medicine , semaglutide , lixisenatide , liraglutide , dulaglutide , type 2 diabetes , exenatide , renal function , diabetes mellitus , kidney disease , glucagon like peptide 1 receptor , albuminuria , endocrinology , agonist , receptor
Glucagon‐like peptide‐1 receptor agonists have been recommended in diabetic kidney disease patients.